semaglutide studies 2024 Study finds weight loss drug reduced COVID-19 related deaths during the pandemic CROI 2024: HIV studies with

Pharmaceutical companies marketing or developing anti-obesity medications can never hope to fully control the obesity Social Media narrative

Lilly announced the topline results from its phase 3b "TOGETHER PsA" trial, showing that the combination use of ixekizumab (Taltz) and tirzepatide (Zepbound) was superior to IXE alone, yielding both significant weight loss and ACR50 disease control in adults with active psoriatic arthritis (PsA).

SmartRx is on track to reduce GLP-1 medication costs by nearly 80% for its first participating employer

This pro-grade device combines Amber/Yellow, Red, and Infrared wavelengths to support deeper tissue repair and circulation

These medications work by curbing hunger, delaying stomach emptying, and controlling blood sugar levels

Intramuscular wellness injections are administered by licensed nurses under the supervision of a licensed physician